Overweight clinical trials
202 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity
- Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
- Effect of Maridebart Cafraglutide on How Oral Contraceptives Are Absorbed and Processed in the Body in Postmenopausal Female Participants Living With Overweight or Obesity
- A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects
- Semaglutide Delivered Epi-Intradermally by Microarray Patch (VX-201) Versus Subcutaneous Administration in Healthy Overweight and Obese Participants
- A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight
- A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets
- A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)
- A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity
- Weight Management Intervention in College: A Pilot
- Pilot Testing a Novel Approach to Pediatric Obesity Treatment
- An Acceptance-Based Healthy Lifestyle Intervention for Diverse Adolescents
- Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
- A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Metabolic Health, Bones and Nuts During Weight Loss in Adults
- Craving Network Neurofeedback
- Efficacy of mHealth Applications in Weight Management in a Population Affected by Overweight or Obesity
- Dietary Supplementation on Fat Oxidation
- A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults
- Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
- Remote Approaches for Optimizing Weight Loss (Elevate Weight Loss Trial)
- A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
- A Study on How NNC0174-1213 Works in People With Overweight or Obesity.
- A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight
- Microrandomized Trial to Optimize Use of Burden-reducing Self-monitoring Approaches in Behavioral Obesity Treatment
- Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households
- Muscle and Movement With Anti-Obesity Medications
- Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
- A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Tablets in Non-diabetic Overweight or Obese Adult Subjects
- Examining Valence-based Effects in Self-Monitoring Feedback Messages
- Comparision of Aerobic Exercise to Aerobic Plus Yoga Exercise for Weight Loss in Adults With Overweight or Obesity.
- A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
- Control Systems Engineering for Weight Loss Maintenance
- Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM1812 Injection Following Single and Multiple Subcutaneous Administration in Normal to Overweight or Obese But Otherwise Healthy Men and Women
- Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity
- Avoid and Resist Strategies for Weight Management
- Optimal Digital Weight Loss Treatment for Rural Individuals
- Water Intake and Weight Control in Older Adults
- A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes
- A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity
- Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
- A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity
- AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Overweight” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.